In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity

被引：4

作者：

Santacroce, R

Bossone, A

Brancaccio, V

Fortina, P

Margaglione, M

机构：

[1] IRCCS, Unita Aterosclerosi & Trombosi, I-71013 San Giovanni Rotondo, FG, Italy

[2] Osped Antonio Cardarelli, Unita Coagulaz, Div Ematol, Naples, Italy

[3] Univ Palermo, Ist Med Interna & Geriatr, I-90133 Palermo, Italy

[4] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Mol Biol Diagnost Unit, Philadelphia, PA 19104 USA

来源：

THROMBOSIS AND HAEMOSTASIS | 2000年 / 83卷 / 06期

关键词：

D O I：

10.1055/s-0037-1613951

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：963 / 964

页数：2

共 8 条

[1]

Ames PRJ, 1996, THROMB HAEMOSTASIS, V76, P190

[2] A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype [J].

Bernardi, F ;

Faioni, EM ;

Castoldi, E ;

Lunghi, B ;

Castaman, G ;

Sacchi, E ;

Mannucci, PM .

BLOOD, 1997, 90 (04) :1552-1557

[3] PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM [J].

DAHLBACK, B .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :923-927

[4]

Franco RF, 1998, BRIT J HAEMATOL, V103, P888

[5]

KOELEMAN BPC, 1994, BLOOD, V84, P1031

[6]

Margaglione M, 1999, THROMB HAEMOSTASIS, V81, P486

[7] Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism [J].

Rodeghiero, F ;

Tosetto, A .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (08) :643-+

[8] Factor V Cambridge:: A new mutation (Arg306→Thr) associated with resistance to activated protein C [J].

Williamson, D ;

Brown, K ;

Luddington, R ;

Baglin, C ;

Baglin, T .

BLOOD, 1998, 91 (04) :1140-1144

← 1 →